Want to see CH:SDZ full AI Analyst Report?

Sandoz Group Ltd (SDZ) Earnings Dates, Call Summary & Reports

Q: What is the P/E ratio of Sandoz Group Ltd stock?

The P/E ratio of {name} is N/A.

33 Followers

Earnings Data

Report Date

Aug 05, 2026

Before Open (Confirmed)

Period Ending

2026 (Q2)

Consensus EPS Forecast

1.45

Last Year’s EPS

1.18

Same Quarter Last Year

Analyst Consensus

Moderate Buy

Based on 6 Analysts Ratings

Earnings Call Summary

Q4 2023

Earnings Call Date:Mar 13, 2024|

% Change Since:

Earnings Call Sentiment|Neutral

The earnings call presented a mixed picture with strong sales growth, particularly in the biosimilars segment and North American market recovery. However, the financial performance was impacted by negative free cash flow, a decline in core EBITDA margin, significant restructuring, and legal costs.

Company Guidance

During the Sandoz Q4 2023 earnings call, the company reported a strong financial performance, exceeding sales growth guidance with a 7% increase to $9.6 billion for the year and achieving a core EBITDA of $1.7 billion, reflecting an 18.1% margin. The biosimilar segment saw significant growth, contributing 23% to total sales, up from 20% in 2022, with products like Omnitrope and the launch of Hyrimoz in the U.S. playing key roles. Despite a negative free cash flow of $234 million due to initial investments post-spin-off, Sandoz anticipates a robust cash flow increase by 2028. Looking forward to 2024, the company expects mid-single-digit net sales growth and core EBITDA margins to reach around 20%, driven by continued biosimilar momentum and operational efficiencies.

Strong Sales Growth

Fourth quarter 2023 was the strongest consecutive quarter of top line growth, with sales up 10% compared to the previous year. For the full year, sales grew 7% to $9.6 billion, with volume contributing 10 percentage points of growth.

Biosimilars Performance

Biosimilars were up 26% in Q4, with significant contributions from the U.S. launch of Hyrimoz and continued demand for Omnitrope. Full-year biosimilars growth was 15%, raising their share of total sales to 23%.

North American Market Recovery

The North American region returned to growth, increasing by 20% in Q4. This was driven by rebuilding the pipeline, strengthening customer relationships, and strong biosimilar performance.

Strategic Acquisitions

The acquisition of CIMERLI from Coherus was completed ahead of schedule, establishing a commercial platform in the U.S. retina market and expanding the ophthalmology portfolio.

Sustainability Initiatives

Sandoz submitted a commitment letter to the SBTI, planning to set science-based carbon emission reduction targets in line with the Paris Agreement goals.

Sandoz Group Ltd (CH:SDZ) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CH:SDZ Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 05, 2026	2026 (Q2)	1.45 / -	1.181	―	―	―
Feb 25, 2026	2025 (Q4)	1.40 / 1.64	1.286	27.36% (+0.35)
Aug 07, 2025	2025 (Q2)	0.99 / 1.18	0.906	30.36% (+0.28)
Mar 05, 2025	2024 (Q4)	1.32 / 1.29	0.801	60.61% (+0.49)
Aug 08, 2024	2024 (Q2)	0.81 / 0.91	0.971	-6.67% (-0.06)
Mar 13, 2024	2023 (Q4)	0.40 / 0.80	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CH:SDZ Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Feb 25, 2026	CHF64.85	CHF71.55	+10.33%
Aug 07, 2025	CHF44.70	CHF49.91	+11.67%
Mar 05, 2025	CHF38.42	CHF38.50	+0.20%
Aug 08, 2024	CHF34.66	CHF33.88	-2.24%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sandoz Group Ltd (CH:SDZ) report earnings?

Sandoz Group Ltd (CH:SDZ) is schdueled to report earning on Aug 05, 2026, Before Open (Confirmed).

What is Sandoz Group Ltd (CH:SDZ) earnings time?

Sandoz Group Ltd (CH:SDZ) earnings time is at Aug 05, 2026, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Sandoz Group Ltd stock?

The P/E ratio of Sandoz Group Ltd is N/A.

What is CH:SDZ EPS forecast?

CH:SDZ EPS forecast for the fiscal quarter 2026 (Q2) is 1.45.